Regulatory Trend of FDA in AI-based Computer-aided Detection/Diagnosis (AI-CAD) System
2019 Volume 9 Issue 1 Pages 37-42
Details
2019 Volume 9 Issue 1 Pages 37-42
In 2018, in the computer-aided detection/diagnosis (CAD) system for medical images, it was a year commemorating the 20th anniversary of commercialization in the United States. Twenty years have passed, and especially with the development of deep learning technology in AI (artificial intelligence), CAD has evolved and diversified as AI-CAD. Along with that, the FDA has also undergone a change in the review status of CAD and its related areas. This article will touch on part of the current situation.
